1 Corporate Drive
South San Francisco, CA 94080
Proprietary Platform to Decode the Cellular Language for Efficient Drug Discovery
As cells sense their environment, they display global cellular responses as feature-rich images known as Cellular Language. Our proprietary platform allows us to decode Cellular Language, enabling unprecedented application of anticipatory biology to evaluate molecules and predict cell fate.
Proprietary, validated, high-throughput: >100K molecules evaluated weekly
We have established a growing pipeline for both oncological and non-oncological implications backed by reproducible, high-quality data.
Graded Cellular Language correlates with clinical disease severity. Our proprietary platform technology transcends the capabilities of cell painting. Our highly sensitive, mechanistically driven process allows us to track and monitor hundreds of proteins and their movements.
This enables our nuanced modulation toward cell death vs. rejuvenation, which spotlights potential drug candidates.
(oncology and infectious disease applications)
(neurodegenerative, muscular dystrophy and numerous other applications)
Our work revolves around the notion that cells are the most powerful computers ever created. Our scientific process, combined with the power of AI/ML, help us gain fluency in this cellular language and revolutionize drug discovery.
Soley Therapeutics is unveiling multiple near-term value catalysts across biopharma and tech arms.
Co-Founder, CEO, Board Member